1.13.11.53: acireductone dioxygenase (Ni2+-requiring)
This is an abbreviated version!
For detailed information about acireductone dioxygenase (Ni2+-requiring), go to the full flat file.
Word Map on EC 1.13.11.53
-
1.13.11.53
-
salvage
-
monoxide
-
cupins
-
mta
-
on-pathway
-
oxytoca
-
nickel-containing
-
ketoacid
-
ni2+-containing
-
membrane-type
-
submergence-induced
-
nickel-dependent
-
nickelii
-
nife-hydrogenase
-
benzil
-
2-keto-4-methylthiobutyrate
-
ch3cn
-
metallocenters
-
analysis
- 1.13.11.53
-
salvage
- monoxide
-
cupins
- mta
-
on-pathway
- oxytoca
-
nickel-containing
-
ketoacid
-
ni2+-containing
-
membrane-type
-
submergence-induced
-
nickel-dependent
-
nickelii
- nife-hydrogenase
- benzil
- 2-keto-4-methylthiobutyrate
- ch3cn
-
metallocenters
- analysis
Reaction
Synonyms
2-hydroxy-3-keto-5-thiomethylpent-1-ene dioxygenase, aci-reductone dioxygenase, acidoreductone dioxygenase, acireductone dioxygenase, acireductone dioxygenase 1, ADI1, ARD, ARD1, human aci-reductone dioxygenase 1, membrane-type 1 matrix metalloproteinase cytoplasmic tail binding protein-1, MTCBP1, MtnD, Ni(II)-ARD, Ni(II)-bound acireductone dioxygenase, Ni-ARD, nickel acireductone dioxyegenase, nickel acireductone dioxygenase, Sip-L
ECTree
Advanced search results
General Information
General Information on EC 1.13.11.53 - acireductone dioxygenase (Ni2+-requiring)
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
physiological function
additional information
-
upon splitting of dioxygen, the enzyme immediately decomposes the reacting system into its three experimentally found products. crystal structure analysis, structure modeling and molecular simulations of the Ni2+ and Fe2+ enzyme, cf. 1.13.11.54, QM-DMD domain, overview
-
either facilitates recycling of methionine in living cells or exits this recycling pathway. Ni2+-dependent ARD produces methylthiopropionate, CO, and formate
physiological function
enzyme expression promotes 5'-methylthioadenosine cycle to increase S-adenosylmethionine levels, which alter genome-wide promoter methylation profiles, resulting in altered gene expression and hepatocellular carcinoma growth suppression